NO994250L - Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer - Google Patents

Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer

Info

Publication number
NO994250L
NO994250L NO994250A NO994250A NO994250L NO 994250 L NO994250 L NO 994250L NO 994250 A NO994250 A NO 994250A NO 994250 A NO994250 A NO 994250A NO 994250 L NO994250 L NO 994250L
Authority
NO
Norway
Prior art keywords
cash
modulators
domain
function
death effect
Prior art date
Application number
NO994250A
Other languages
English (en)
Norwegian (no)
Other versions
NO994250D0 (no
Inventor
David Wallach
Yura Goltsev
Andrei Kovalenko
Eugene Varfolomeev
Vadim Brodianski
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12036797A external-priority patent/IL120367A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO994250D0 publication Critical patent/NO994250D0/no
Publication of NO994250L publication Critical patent/NO994250L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO994250A 1997-03-03 1999-09-02 Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer NO994250L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12036797A IL120367A0 (en) 1997-03-03 1997-03-03 Modulators of the function of FAS receptors and other proteins
IL12075997A IL120759A0 (en) 1997-03-03 1997-05-01 Modulators of the function of fas receptors and other proteins
PCT/IL1998/000098 WO1998039435A1 (fr) 1997-03-03 1998-02-26 Proteines cash (homologue de caspase) presentant un domaine effecteur de mort, modulatrices de la fonction des recepteurs fas

Publications (2)

Publication Number Publication Date
NO994250D0 NO994250D0 (no) 1999-09-02
NO994250L true NO994250L (no) 1999-11-02

Family

ID=26323378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994250A NO994250L (no) 1997-03-03 1999-09-02 Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer

Country Status (19)

Country Link
US (1) US7419804B2 (fr)
EP (1) EP0977842A1 (fr)
JP (1) JP2002500508A (fr)
KR (1) KR100544776B1 (fr)
CN (1) CN1148446C (fr)
AU (1) AU740223B2 (fr)
BG (1) BG64799B1 (fr)
BR (1) BR9808173A (fr)
CA (1) CA2281484A1 (fr)
EA (1) EA003269B1 (fr)
EE (1) EE9900384A (fr)
HK (1) HK1024508A1 (fr)
HU (1) HUP0000913A3 (fr)
IL (3) IL120759A0 (fr)
NO (1) NO994250L (fr)
NZ (1) NZ337143A (fr)
PL (1) PL193394B1 (fr)
SK (1) SK117599A3 (fr)
WO (1) WO1998039435A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713393C2 (de) * 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein
DE19713434C1 (de) * 1997-04-01 1998-09-24 Deutsches Krebsforsch Protein zur Inhibierung von Apoptose
JP2002520025A (ja) * 1998-07-08 2002-07-09 メルク フロスト カナダ アンド カンパニー 哺乳動物ｄｅｄ−カスパーゼ相同体ユサルピン
US7052834B1 (en) 1998-12-31 2006-05-30 St. Jude Children's Research Hospital Tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
WO2000039347A1 (fr) * 1998-12-31 2000-07-06 St. Jude Children's Research Hospital Proteine de suppression de tumeur, impliquee dans la transmission des signaux de mort, et methodes diagnostiques, therapeutiques et de criblage basees sur cette proteine
US20020174450A1 (en) * 2000-12-11 2002-11-21 Allen Keith D. Transgenic mice containing cash gene disruptions
CN110988354A (zh) * 2019-11-15 2020-04-10 同济大学 一种分泌蛋白Caspase1在早期心梗诊断试剂中的应用
CN116426678B (zh) * 2023-03-27 2024-03-22 中国热带农业科学院三亚研究院 与番木瓜果肉果糖含量相关的snp分子标记及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
EP0841399A3 (fr) * 1996-11-12 1998-07-08 Smithkline Beecham Corporation L'acide nucléotique de fin-1 humaine (une caspase) et séquence de la protéine et ses applications
JP2001511011A (ja) 1997-01-21 2001-08-07 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 腫瘍壊死因子レセプター−１誘導性アポトーシスおよびｃｄ−９５誘導性アポトーシスの新規なインヒビターである、ｉ−ｆｌｉｃｅ
US6242569B1 (en) 1997-02-05 2001-06-05 Tularik, Inc. Regulators of apoptosis
DE19713393C2 (de) * 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein
US6207458B1 (en) * 1998-05-07 2001-03-27 University Of Washigton/Stowers Insitute For Medical Research Proteins capable of regulating NF-κB JNK and apoptosis pathways and methods of using the same

Also Published As

Publication number Publication date
EA199900794A1 (ru) 2000-04-24
CA2281484A1 (fr) 1998-09-11
BG64799B1 (bg) 2006-04-28
NO994250D0 (no) 1999-09-02
US20060216788A1 (en) 2006-09-28
HK1024508A1 (en) 2000-10-13
IL120759A0 (en) 1997-09-30
NZ337143A (en) 2001-12-21
HUP0000913A3 (en) 2001-11-28
EP0977842A1 (fr) 2000-02-09
WO1998039435A1 (fr) 1998-09-11
AU740223B2 (en) 2001-11-01
HUP0000913A2 (hu) 2000-06-28
EE9900384A (et) 2000-04-17
SK117599A3 (en) 2000-05-16
CN1148446C (zh) 2004-05-05
US7419804B2 (en) 2008-09-02
BR9808173A (pt) 2000-05-16
CN1249780A (zh) 2000-04-05
JP2002500508A (ja) 2002-01-08
IL131247A0 (en) 2001-01-28
EA003269B1 (ru) 2003-02-27
PL193394B1 (pl) 2007-02-28
KR20000075721A (ko) 2000-12-26
BG103693A (en) 2000-05-31
KR100544776B1 (ko) 2006-01-23
IL131247A (en) 2007-08-19
AU6112698A (en) 1998-09-22
PL335448A1 (en) 2000-04-25

Similar Documents

Publication Publication Date Title
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE69605903D1 (de) Verriegelungskupplung
DE69625233D1 (de) Einrichtung vom flipchiptyp
DE69609822D1 (de) Schutzvliesschichtstoff
DE69816443D1 (de) Sicherheitsspritze
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69812708T2 (de) Neue arzneimittel enthaltend uridintriphosphat
DE69836697D1 (de) Neue 3,6-Hemiketale der 9a-Azalidklasse
FI962499A (fi) Herbisidien tehon parantaminen
NO994250L (no) Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer
ATA2895A (de) Streugerät
FR2786345B1 (fr) Dispositif de cryptage quantique
DE69830259D1 (de) Gewebeschutzmittel und der Gebrauch desselben
NO953050D0 (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
DE59802124D1 (de) Flüssigkeitsverteilvlies
DE59306744D1 (de) Mittel zur festigung der haare
FR2762366B1 (fr) Dispositif d'assemblage, notamment pour meubles
FI953081A (fi) Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin
KR970023536U (ko) 투포원의 연사기를 이용하여 복합사를 제조하는 합사장치
FR2757582B1 (fr) Dispositif d'assemblage de securite
KR970036125U (ko) 아웃사이드 미러의 동결 방지장치
KR970050187U (ko) 지폐의 강제역송 차단잠금장치
KR970008260U (ko) 농용 액체 살포기
FR2758470B1 (fr) Le porteur
KR970015670U (ko) 패스워드기능을 갖는 모니터

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application